Q2 Trademark - Serial Number 86680065

Serial Number
86680065
Word Mark
Q2
Filing Date
Status
REGISTERED
Status Date
2019-12-31
Registration Number
5950382
Registration Date
2019-12-31
Type of Mark
Service Mark
Mark Drawing
Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form Typeset
Published for Opposition Date
2016-09-27
Attorney Name
Arlene D. Hanks

Statements

Indication of Colors claimed

Color is not claimed as a feature of the mark.

Description of Mark

The mark consists of the letter "Q" followed by a superscript number "2".

Goods and Services

(035) Computerized database management and data processing services in the pharmaceutical, pharmacogenomic, biomarker, biopharmaceutical, medical device and diagnostics fields; providing business information, namely, information related to regulatory approval and marketing of drugs, devices, health care or medical products and services, and biologics; none of the foregoing for use in the field of Medicare

(042) Clinical research and testing services, in the fields of clinical trials, health care products, pharmaceutical products, pharmacogenomics products, biomarker products, biopharmaceutical products, medical devices and diagnostics products; product development consultation in the fields of health care, medical products and devices; health care research and product development services; medical and laboratory testing services for research purposes; laboratory testing services for research purposes in the fields of health care, clinical trials, pharmaceutical, pharmacogenomics, biomarker, biopharmaceutical, medical device and diagnostics; consultancy in the design, planning and implementation project management of clinical trials; health care medical research consultancy; product development consultancy in the fields of medical diagnostics, medical devices, pharmacology, pharmacogenomics, biomarkers and biopharmaceutical research; managing, namely, monitoring, coordinating and implementing clinical studies being clinical trials on human subjects for others for research purposes; medical and scientific research in the fields of healthcare and medical diagnostics; providing temporary use of non-downloadable, web-based software application for providing access to information and data in the clinical trials, pharmaceutical, pharmacogenomic, biomarker, biopharmaceutical, medical device and diagnostics, life sciences, health management and disease management fields and for organizing and analyzing said data and information and preparing reports therefrom,; providing temporary use of non-downloadable software for providing, managing and analyzing laboratory clinical trial data and information in the fields of pharmaceutical, pharmacogenomic, biomarker, biopharmaceutical, medical device and diagnostics, life sciences, health management and disease management fields; providing temporary use of non-downloadable software that allows remote access to clinical trial peri- and post-approval laboratory data and information; providing temporary use of non-downloadable software for use in collecting and reporting medical data relating to patient medical conditions for research; providing scientific and medical research information relating to the development and validation of drugs, pharmaceutical products, medical products, medical devices and biologics; providing an internet website portal featuring scientific and medical research information in the fields of clinical trials, pharmaceutical research, pharmacogenomic and biomarker consultation, biopharmaceutical consultation, medical devices and diagnostics, life sciences research, and medical research; providing an online searchable database via the internet featuring medical and scientific research information in the fields of clinical trials, companion diagnostics, pharmaceutical research, pharmacogenomic and biomarkers, biopharmaceuticals, medical devices and diagnostics, life sciences research, and medical research; all of the foregoing relating to clinical trials, clinical research, medical and scientific laboratory services, biopharmaceutical, biomarker, diagnostics and medical product and device development, and research, testing, regulatory approval and commercialization of diagnostics, biopharmaceuticals, biomarkers and medical products and devices and none of the foregoing for use in the field of Medicare or related to Medicare or other governmental health programs

(044) Providing health and medical information; providing pharmaceutical information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; providing medical information relating to pharmacogenomics and biomarkers; health management and disease management medical information to others; medical evaluation services; medical consulting services in the fields of health care, medicine, life sciences, and pharmaceuticals, biopharmaceuticals, biomarkers, pharmacogenomics, medical device and diagnostics; providing an online interactive computer database in the field of healthcare featuring healthcare information; providing an Internet website portal featuring medical and healthcare information in the fields of medical services, health care, health management and disease management; providing an online searchable database via the internet featuring medical and healthcare information in the fields of medical services, medical devices and diagnostics, health care, health management and disease management; none of the foregoing for use in the field of Medicare

(045) Regulatory compliance research and consulting services in the fields of health care, clinical trials, development and testing of drugs, devices, biologics and methodologies used in the pharmaceutical industry, biotechnology industry and the medical device and diagnostics industry; consulting services in the fields of regulatory affairs, namely, regulatory compliance consulting in the field of prescription drug sampling; manufacturing compliance and validation procedures, namely, reviewing standards and practices to assure compliance with clinical trial regulations, medical and laboratory testing services; providing regulatory information, namely, providing regulatory compliance information regarding the examination and approval process of pharmaceutical, biotechnical, medical and diagnostic products and methodologies by governmental regulatory bodies; providing regulatory compliance consulting services relating to the development and validation of drugs, devices and biologics, namely, assisting others in implementing procedures that comply with regulatory requirements; none of the foregoing for use in the field of Medicare

Pseudo Mark

Q TWO

Classification Information

International Class
(035) Advertising; business management; business administration; office functions.
US Class Codes
100, 101, 102
Class Status
Active
Class Status Date
2015-07-07
Primary Code
035
First use anywhere
20190400
First use in commerce
20190400
International Class
(042) Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes
100, 101
Class Status
Active
Class Status Date
2015-07-07
Primary Code
042
First use anywhere
20190400
First use in commerce
20190400
International Class
(044) Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status
Active
Class Status Date
2015-07-07
Primary Code
044
First use anywhere
20190400
First use in commerce
20190400
International Class
(045) Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes
100, 101
Class Status
Active
Class Status Date
2015-07-07
Primary Code
045
First use anywhere
20190400
First use in commerce
20190400

Current Owner

Original Registrant

Address

Please login to see owner's address

Legal Entity Type
Limited Liability Company

Trademark Owner History

Original Applicant

Address

Please login to see owner's address

Legal Entity Type
Limited Liability Company

Owner at Publication

Address

Please login to see owner's address

Legal Entity Type
Limited Liability Company

Original Registrant

Address

Please login to see owner's address

Legal Entity Type
Limited Liability Company

Correspondences

Party Name
ARLENE D. HANKS, Moore & Van Allen PLLC
Address

Please login to see Correspondences information

Trademark Events

Event Date
Event Description
2019-12-31
REGISTERED-PRINCIPAL REGISTER
2019-11-26
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
2019-11-25
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
2019-11-18
STATEMENT OF USE PROCESSING COMPLETE
2019-11-13
USE AMENDMENT FILED
2019-11-13
TEAS STATEMENT OF USE RECEIVED
2019-05-22
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2019-05-21
EXTENSION 5 GRANTED
2019-05-21
CASE ASSIGNED TO INTENT TO USE PARALEGAL
2019-05-17
EXTENSION 5 FILED
2019-05-17
TEAS EXTENSION RECEIVED
2018-12-19
TEAS CHANGE OF CORRESPONDENCE RECEIVED
2018-10-27
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2018-10-25
EXTENSION 4 GRANTED
2018-10-25
EXTENSION 4 FILED
2018-10-25
TEAS EXTENSION RECEIVED
2018-05-16
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2018-05-14
EXTENSION 3 GRANTED
2018-05-14
EXTENSION 3 FILED
2018-05-14
TEAS EXTENSION RECEIVED
2017-11-09
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2017-11-07
EXTENSION 2 GRANTED
2017-11-07
EXTENSION 2 FILED
2017-11-07
TEAS EXTENSION RECEIVED
2017-05-12
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2017-05-10
EXTENSION 1 GRANTED
2017-05-10
EXTENSION 1 FILED
2017-05-10
TEAS EXTENSION RECEIVED
2016-11-22
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2016-09-27
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2016-09-27
PUBLISHED FOR OPPOSITION
2016-09-07
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2016-08-25
LAW OFFICE PUBLICATION REVIEW COMPLETED
2016-08-23
APPROVED FOR PUB - PRINCIPAL REGISTER
2016-08-18
EXAMINER'S AMENDMENT ENTERED
2016-08-17
ASSIGNED TO LIE
2016-08-17
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2016-08-17
EXAMINERS AMENDMENT E-MAILED
2016-08-17
EXAMINERS AMENDMENT -WRITTEN
2016-05-09
NOTIFICATION OF FINAL REFUSAL EMAILED
2016-05-09
FINAL REFUSAL E-MAILED
2016-05-09
FINAL REFUSAL WRITTEN
2016-04-16
TEAS/EMAIL CORRESPONDENCE ENTERED
2016-04-15
CORRESPONDENCE RECEIVED IN LAW OFFICE
2016-04-15
TEAS RESPONSE TO OFFICE ACTION RECEIVED
2015-10-20
NOTIFICATION OF PRIORITY ACTION E-MAILED
2015-10-20
PRIORITY ACTION E-MAILED
2015-10-20
PRIORITY ACTION WRITTEN
2015-10-12
ASSIGNED TO EXAMINER
2015-07-08
NOTICE OF PSEUDO MARK E-MAILED
2015-07-07
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2015-07-04
NEW APPLICATION ENTERED IN TRAM